Corteva (NYSE:CTVA – Get Free Report) posted its earnings results on Wednesday. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.10, Briefing.com reports. The business had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.65 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.16 EPS. Corteva updated its FY 2024 guidance to 2.700-2.900 EPS and its FY24 guidance to $2.70-$2.90 EPS.
Corteva Price Performance
Shares of NYSE CTVA traded up $3.30 during midday trading on Thursday, reaching $57.21. 3,959,540 shares of the stock traded hands, compared to its average volume of 3,517,307. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.56 and a quick ratio of 0.90. The stock has a market capitalization of $39.98 billion, a PE ratio of 55.92, a P/E/G ratio of 1.42 and a beta of 0.78. Corteva has a one year low of $43.22 and a one year high of $61.07. The company’s 50 day moving average is $55.28 and its 200 day moving average is $50.56.
Corteva Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.12%. Corteva’s dividend payout ratio is currently 62.75%.
Wall Street Analyst Weigh In
Get Our Latest Research Report on CTVA
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also
- Five stocks we like better than Corteva
- Buy P&G Now, Before It Sets A New All-Time High
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- What does consumer price index measure?
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- Stock Sentiment Analysis: How it Works
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.